Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Dyspnea × Surveys and Questionnaires × Clear all

Phase

Status

Completed 3 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Recurrence 2 Neoplasm Metastasis 2 Head and Neck Neoplasms 2 cyclopia sequence 1 Sezary Syndrome 1 Seroma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polyneuropathies 1 Peripheral Nervous System Diseases 1 Patient Education 1 Pain 1 Ovarian Neoplasms 1 Occupational Stress 1 Neoplasms, Plasma Cell 1 Mycosis Fungoides 1 Mouth Neoplasms 1 Mesothelioma 1 Malignant Neoplasms of Independent (Primary) Multiple Sites 1 Malignant Neoplasms of Female Genital Organs 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma 1 Lung Diseases 1 Glioblastoma 1 Esophageal Neoplasms 1 Dyspnea 1

Interventions

Surveys and Questionnaires 1 Midazolam 1 Losartan 1 Furosemide 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01518140 2013-08-13

BiPAP-Vapotherm RCT

M.D. Anderson Cancer Center

Phase 2 Withdrawn

Dyspnea, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡